TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
AdAlta Ltd. ( (AU:1AD) ) has shared an announcement.
AdAlta Ltd. has announced a security consolidation, affecting several of its securities, including ordinary shares and performance rights. This reorganization is set to commence trading on a deferred settlement basis from December 9, 2025, with the record date on December 10, 2025, and the issue date on December 17, 2025. The consolidation is part of the company’s strategic financial restructuring, potentially impacting its market positioning and shareholder value.
More about AdAlta Ltd.
AdAlta Ltd. operates in the biotechnology industry, focusing on the development of novel therapeutic products. The company is known for its proprietary i-body technology, which is used to create a new class of drugs aimed at treating challenging diseases.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$8.45M
Learn more about 1AD stock on TipRanks’ Stock Analysis page.